ROCKWELL MEDICAL INC (RMTI:NASDAQ)
$0.9147 -0.0015 (-0.1637%)
Analysed ROCKWELL MEDICAL INC (RMTI:NASDAQ) News Sources
Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026
09-04-2026
yahoo.com
Should Value Investors Buy Rockwell Medical (RMTI) Stock?
27-03-2026
yahoo.com
Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain
27-03-2026
yahoo.com
Rockwell Medical Inc (RMTI) Q4 2025 Earnings Call Highlights: Navigating Challenges with ...
26-03-2026
yahoo.com
Rockwell Medical, Inc. Q4 2025 Earnings Call Summary
26-03-2026
moby.co
Rockwell Medical (RMTI) Reports Q4 Loss, Misses Revenue Estimates
26-03-2026
yahoo.com
Rockwell Medical: Q4 Earnings Snapshot
26-03-2026
yahoo.com
Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results
26-03-2026
yahoo.com
Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026
26-02-2026
yahoo.com
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
16-02-2026
yahoo.com
What is the current price of ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The current price of ROCKWELL MEDICAL INC (RMTI:NASDAQ) is $0.9147.
ROCKWELL MEDICAL INC (RMTI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROCKWELL MEDICAL INC (RMTI:NASDAQ) since the previous trading day is $-0.0015.
ROCKWELL MEDICAL INC (RMTI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROCKWELL MEDICAL INC (RMTI:NASDAQ) since the previous trading day is -0.1637%.
What is the most recent average sentiment score for ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The most recent average sentiment score for ROCKWELL MEDICAL INC (RMTI:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for ROCKWELL MEDICAL INC (RMTI:NASDAQ)?
The most recent sentiment for ROCKWELL MEDICAL INC (RMTI:NASDAQ) is .
SEC-8K** Filing Available For ROCKWELL MEDICAL INC (RMTI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.